Oberweis Asset Management Inc. boosted its position in Genpact Limited (NYSE:G - Free Report) by 18.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 523,600 shares of the business services provider's stock after buying an additional 81,200 shares during the quarter. Genpact makes up approximately 1.1% of Oberweis Asset Management Inc.'s portfolio, making the stock its 16th biggest position. Oberweis Asset Management Inc. owned about 0.30% of Genpact worth $22,489,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in G. Coppell Advisory Solutions LLC boosted its stake in Genpact by 529.5% in the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares in the last quarter. SRH Advisors LLC purchased a new position in Genpact during the fourth quarter valued at $26,000. Atlas Capital Advisors Inc. increased its stake in Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares during the last quarter. Manchester Capital Management LLC purchased a new stake in Genpact during the 4th quarter valued at $38,000. Finally, GeoWealth Management LLC grew its holdings in Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after purchasing an additional 583 shares during the last quarter. 96.03% of the stock is owned by institutional investors.
Genpact Price Performance
G stock opened at $47.58 on Thursday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The business has a 50 day simple moving average of $50.04 and a 200-day simple moving average of $46.20. The firm has a market capitalization of $8.36 billion, a PE ratio of 16.75, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. Genpact Limited has a 1 year low of $30.38 and a 1 year high of $56.76.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Equities research analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.43%. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. Genpact's payout ratio is 23.94%.
Insider Buying and Selling at Genpact
In other news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. The trade was a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.80% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on G shares. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and upped their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and increased their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Needham & Company LLC raised their price objective on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Finally, Mizuho raised their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $50.38.
View Our Latest Analysis on G
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.